Genenta Science S.p.A. financial data

Symbol
GNTA on Nasdaq
Location
Milan, Italy
Latest financial report
20-F - Q4 2024 - 28 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,289,866 shares 0.4%
Common Stock, Shares, Outstanding 18,289,866 shares 0.4%
Common Stock, Value, Issued €68,462,280 EUR 1.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value €4,581,749 EUR 24%
Marketable Securities, Current €8,078,002 EUR -46%
Cash, Cash Equivalents, and Short-term Investments €12,700,000 EUR -32%
Other Assets, Current €210,830 EUR 226%
Assets, Current €14,472,977 EUR -32%
Property, Plant and Equipment, Net €42,922 EUR -48%
Assets €14,823,993 EUR -34%
Liabilities, Current €2,099,362 EUR 21%
Operating Lease, Liability, Noncurrent €7,981 EUR -62%
Other Liabilities, Noncurrent €1,158 EUR -92%
Accumulated Other Comprehensive Income (Loss), Net of Tax €88,946 EUR -62%
Retained Earnings (Accumulated Deficit) €56,055,520 EUR -19%
Stockholders' Equity Attributable to Parent €12,495,706 EUR -39%
Liabilities and Equity €14,823,993 EUR -34%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 59,700,000 shares 0%
Common Stock, Shares, Issued 18,289,866 shares 0.4%
Common Stock, Par or Stated Value Per Share 0 EUR/shares
Deferred Tax Assets, Valuation Allowance €14,487,319 EUR 17%
Deferred Tax Assets, Gross €14,487,319 EUR 17%
Lessee, Operating Lease, Liability, to be Paid €7,575 EUR -67%
Property, Plant and Equipment, Gross €141,245 EUR 3.3%
Operating Lease, Liability, Current €13,023 EUR 6.4%
Deferred Tax Assets, Operating Loss Carryforwards €13,876,117 EUR 18%